Priorities for biosimilars in the NHS

29/04/2021

A virtual event hosted by the Westminster Health Forum. It examines key issues for the use and uptake of biosimilars in the NHS.


The conference takes place with the UK’s final regulatory guidance for biosimilars expected shortly, following the end of the transition from the EU, as well as the drive within the NHS to reduce medicine costs and achieve value for money.

More information

Ask for a Free trial and get access to the latest stories

Our coverage includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.

REQUEST

an initial 10 day temporary access of APM Health Europe.